Evidence map›Paper›PMID 36989449›Full record

ArticleJournal of managed care & specialty pharmacy2023

Health disparity in use of novel agents for first-line therapy in Black and White patients with chronic lymphocytic leukemia in the Department of Veterans Affairs.

Kana Tai Lucero, Obiageri O Obodozie-Ofoegbu, Zohra Nooruddin, Kellie Ryan, Alyssa Castillo, Amanda M Moore, Xavier Jones, Christopher R Frei

Open access · greenAbstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Diminishing Returns Among Black Patients With Cancer: The Intersection of Race and Neighborhood Socioeconomic Status.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Article
  3. Advancing the conversation: 30 years of scholarship in managed care pharmacy.Journal of managed care & specialty pharmacy · 2025
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kana Tai LuceroLong School of Medicine, University of Texas Health San Antonio.
Obiageri O Obodozie-OfoegbuLong School of Medicine, University of Texas Health San Antonio.
Zohra NooruddinLong School of Medicine, University of Texas Health San Antonio.
Kellie RyanAstraZeneca US Medical Affairs, Gaithersburg, MD.
Alyssa CastilloLong School of Medicine, University of Texas Health San Antonio.
Amanda M MooreCollege of Pharmacy, The University of Texas at Austin, San Antonio.
Xavier JonesLong School of Medicine, University of Texas Health San Antonio.
Christopher R FreiLong School of Medicine, University of Texas Health San Antonio.
South Texas Veterans Health Care System · USThe University of Texas Health Science Center at San Antonio · USAstraZeneca (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellVeteransAgedBlack or African AmericanHumansRetrospective StudiesUnited StatesUnited States Department of Veterans AffairsWhite

Identifiers

PMID36989449
PMCPMC10387978
OpenAlexW4361283274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.